Saturday, June 03, 2017 7:36:21 AM
It does not appear that there is any future consideration** to be paid for the technology (i.e. future royalties). This makes me think it is some sort of defensive acquisition -- somebody has a better mousetrap out there so let's lock it up so no competitor can exploit it against us.
The timing of the transaction is intriguing as it relates to the current expected timing of them getting the epidural marketing approval from the FDA. Maybe they've already been told by the FDA to expect the approval to get issued during the week of 6/12. Hopefully they also have lined up a US distributor for the epidural instrument that will be announced around the same time as the marketing approval.
It should be an interesting couple of months coming up here for MLSS fans, if nothing else.
** There is a provision where, if the price of MLSS stock is lower than the price that was used in the transaction at a time that is 6 months after the closing, MLSS will have to issue more shares at that time to make up the difference. Hopefully that provision will turn out to be moot since the epidural instrument will hopefully be selling by then.
Recent MLSS News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 05:07:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 09:05:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 09:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 09:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 09:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 09:03:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 09:03:28 PM
- Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024 • GlobeNewswire Inc. • 08/15/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:00:32 PM
- Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 08/12/2024 03:00:00 PM
- Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida • GlobeNewswire Inc. • 08/07/2024 02:00:00 PM
- Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe • GlobeNewswire Inc. • 07/30/2024 12:30:00 PM
- Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 07:47:33 PM
- Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil • GlobeNewswire Inc. • 06/18/2024 03:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 06:11:22 PM
- Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024 • GlobeNewswire Inc. • 05/16/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:01:31 PM
- Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 05/13/2024 12:30:00 PM
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida • GlobeNewswire Inc. • 04/03/2024 12:30:00 PM
- Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023 • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 03/28/2024 03:45:00 PM
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians • GlobeNewswire Inc. • 03/14/2024 12:30:00 PM
- Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio • GlobeNewswire Inc. • 02/28/2024 01:30:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM